British Columbia Node
BC Node Research Day
The TFRI BC Node will hold its 5th Annual TFRI BC Node Research Day on Nov. 23, 2016 at the Vancouver Coastal Health Research Institute at the Vancouver General Hospital campus.
For more information contact email@example.com.
Node Leader: Dr. Marco Marra
Dr. Marra is director of Canada's Michael Smith Genome Sciences Centre (GSC) at the BC Cancer Agency and a former holder of a Terry Fox Young Investigators Award (2004).
He is a Distinguished Scientist with the BC Cancer Agency, a Professor of Medical Genetics at the University of British Columbia, and an adjunct Professor of Molecular biology and Biochemistry at Simon Fraser University.
Read more about Dr. Marra
BC Node Regional Advisory Committee Members
Mr. Paul Balfour
Paul Balfour is an institutional portfolio manager with RBC Global Asset Management. He is a member of the firm's Executive Committee, responsible for strategic direction and has been a member of the senior management team since 2004. Paul holds a B.A. from McGill University and began his investment career in 1984 as a research analyst. He has worked closely with many of Canada's largest mutual funds, pension funds, investment counsellors and consultants. In 1992, he joined RBC Dominion Securities, a major Canadian investment dealer, subsequently assuming responsibility for that firm's western institutional equity operations before joining Phillips, Hager & North Investment Management in 1998. He is a past vice-chair of the BC Cancer Foundation and is a founder and co-captain of the Horny Goats cycling team which has raised over $1.5 million for cancer research since its inception in 2009.
Dr. Nadine Caron
Dr. Caron was born and raised in Kamloops, BC. She completed her Bachelor of Science in Kinesiology at Simon Fraser University (1993) and her Medical Degree (1997) at the University of British Columbia in Vancouver. Following her graduation Nadine moved to San Francisco to complete her Postgraduate Fellowship Training in Endocrine Surgical Oncology at the University of California. However, her love for BC brought her home and since 2005, Nadine has been working as a General and Endocrine Surgeon at the University Hospital of Northern BC.
Nadine’s main research focus involves health care policy and how it affects Canada`s marginalized populations – including Aboriginal, northern and rural. She holds positions on several boards and committees, including being a founding member of the Northern Aboriginal Cancer Care Advisory Committee.
Dr. Peter Chow-White
Dr. Peter Chow-White is an associate professor in the School of Communication at Simon Fraser University where he is director of the Genomics and Networks Analysis (GeNA) Lab and associate director of the Centre for Policy Research on Science and Technology. He is also an associate professor in the Faculty of Medicine at the University of British Columbia and a member of the Centre for Clinical Diagnostic Genomics at the Genome Sciences Centre. He received his PhD from the Annenberg School for Communication at the University of Southern California in Los Angeles. Peter's research projects examine the social and organizational impacts of new communication technologies, the Internet, and social media on genomics and biomedicine.
Dr. Stuart Peacock
Stuart Peacock is co-director of the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is a pan-Canadian research centre providing interdisciplinary leadership in health economics, services, policy and ethics research. Stuart is also deputy head of Cancer Control Research and a distinguished scientist at the BC Cancer Agency, an associate professor in the School of Population and Public Health at UBC, and president of the International Society on Priorities in Health Care. Previously he held positions at Monash University and the University of York, UK. Stuart's main research interests include priority setting methods, quality of life, and the economics of cancer control. He has acted as a consultant on priority-setting methods to the World Health Organization and to governments in North and South America, Europe, Asia and Australia.
A passionate childhood cancer research advocate, Patrick Sullivan is the president and founder of the Team Finn Foundation, a volunteer-based organization dedicated to raising funds for cutting-edge pediatric cancer research. Since 2009, the foundation has raised over $2M for pediatric cancer research. Patrick is also chair and a founding member of Ac2orn (Advocacy for Canadian Childhood Oncology Research Network), a pan-Canadian science advocacy group dedicated to working with researchers and clinicians as they implement the dream of curing pediatric cancer through translational research and effective treatments. Professionally, Patrick is a securities and corporate-commercial litigator based in Vancouver, B.C. Patrick is also the proud father of three remarkable children and would do almost anything for the simple pleasure of holding Finn's hand again.
Dr. Simon B. Sutcliffe, Chair
A 1970 graduate of St. Bartholomew's Hospital, London, England, Dr. Sutcliffe's training encompassed internal medicine, scientific research, medical and radiation oncology in the U.K., South Africa, U.S. and Canada. He has been president and CEO of the Princess Margaret Hospital/Ontario Cancer Institute (1994-1996) and the BC Cancer Agency (2000- 2009).
He chairs the board of the Institute for Health Systems Transformation and Sustainability; is president of the International Cancer Control Congress Association, the International Network for Cancer Treatment and Research-Canada Branch (Two Worlds Cancer Collaboration); is a senior advisor to the Terry Fox Research Institute; and is chief medical officer for QuBiologics Inc. and Omnitura Inc. He is a past chair of the board of the Canadian Partnership Against Cancer (CPAC, 2009-2012), the Michael Smith Foundation for Health Research (MSFHR, 2006-7) and has served on the boards of CPAC, MSFHR, and Genome BC. He is an adjunct clinical professor at the University of British Columbia and an associate scientist with the Michael Smith Genome Sciences Centre at the BC Cancer Agency.
Dr. Sutcliffe received the Queen Elizabeth 50th Jubilee Gold Medal (2003) and the BC Medical Association Terry Fox Award (2009) for his lifetime services to cancer control.
Back to Top